Contemporary Management of Cardiac Implantable Electronic Device Infection: The American College of Cardiology COGNITO Survey

Overview

Journal JACC Adv

Specialty Cardiology & Vascular Diseases

Date 2024 Jun 28

PMID 38939375

Authors

Dhanunjaya R Lakkireddy

Archana Rao

Paul Theriot

Douglas Darden

Naga Venkata K Pothineni

Rashmi Ram

Yu-Rong Gao

Jim W Cheung

Ulrika Birgersdotter-Green

Affiliations

Soon will be listed here.

Abstract

Background: Cardiac implantable electronic devices (CIEDs) infection remains a serious complication, causing increased morbidity and mortality. Early recognition and escalation to definitive therapy including extraction of the infected device often pose challenges.

Objectives: The purpose of this study was to assess U.S.-based physicians current practices in diagnosing and managing CIED infections and explore potential extraction barriers.

Methods: An observational survey was performed by the American College of Cardiology including U.S. physicians managing CIEDs from February to March 2022. Sampling techniques and screener questions determined eligibility. The survey featured questions on knowledge and experience with CIED infection patients and case scenarios.

Results: Of 387 physicians completing the survey (20% response rate), 49% indicated familiarity with current guidelines regarding CIED infection. Electrophysiologists (EPs) (91%) were more familiar with these guidelines, compared to non-EP cardiologists (29%) and primary care physicians (23%). Only 30% of physicians specified that their institution had guideline-based protocols in place for managing patients with CIED infection. When presented with pocket infection cases, approximately 89% of EPs and 50% of non-EP cardiologists would follow guideline recommendation to do complete CIED system removal, while 70% of primary care physicians did not recommend guideline-directed treatment.

Conclusions: There are gaps in familiarity of guidelines as well as the knowledge in practical management of CIED infection with non-extracting physicians. Most institutions lack a definite pathway. Addressing discrepancies, including guideline education and streamlining care or referral pathways, will be a key factor to bridging the gap and improving CIED infection patient outcomes.

Citing Articles

Impact of hospital lead extraction volume on management of cardiac implantable electronic device-associated infective endocarditis.

Mandler A, Sciria C, Kogan E, Kim I, Yeo I, Simon M Europace. 2024; 27(1.

PMID: 39727102 PMC: 11707385. DOI: 10.1093/europace/euae308.

References

Dai M, Cai C, Vaibhav V, Sohail M, Hayes D, Hodge D . Trends of Cardiovascular Implantable Electronic Device Infection in 3 Decades: A Population-Based Study. JACC Clin Electrophysiol. 2019; 5(9):1071-1080. DOI: 10.1016/j.jacep.2019.06.016. View

Lin A, Saul T, Aldaas O, Lupercio F, Ho G, Pollema T . Early Versus Delayed Lead Extraction in Patients With Infected Cardiovascular Implantable Electronic Devices. JACC Clin Electrophysiol. 2020; 7(6):755-763. PMC: 8209117. DOI: 10.1016/j.jacep.2020.11.003. View

Wilkoff B, Boriani G, Mittal S, Poole J, Kennergren C, Corey G . Impact of Cardiac Implantable Electronic Device Infection: A Clinical and Economic Analysis of the WRAP-IT Trial. Circ Arrhythm Electrophysiol. 2020; 13(5):e008280. PMC: 7237027. DOI: 10.1161/CIRCEP.119.008280. View

Deshmukh A, Patel N, Noseworthy P, Patel A, Patel N, Arora S . Trends in Use and Adverse Outcomes Associated with Transvenous Lead Removal in the United States. Circulation. 2015; 132(25):2363-71. DOI: 10.1161/CIRCULATIONAHA.114.013801. View

Lee J, Tan M, Karikalan S, Deshmukh A, Sorajja D, Valverde A . Causes of Early Mortality After Transvenous Lead Removal. JACC Clin Electrophysiol. 2022; 8(12):1566-1575. DOI: 10.1016/j.jacep.2022.08.006. View

Rao A, Garner D, Starck C, Kirkfeldt R, Dagres N, Didier K . Knowledge gaps, lack of confidence, and system barriers to guideline implementation among European physicians managing patients with CIED lead or infection complications: a European Heart Rhythm Association/European Society of Cardiology educational.... Europace. 2020; 22(11):1743-1753. DOI: 10.1093/europace/euaa218. View

Darden D, Boateng B, Tseng A, Alshawabkeh L, Pollema T, Cha Y . Transvenous laser lead extraction in patients with congenital complete heart block. Heart Rhythm. 2022; 19(7):1158-1164. DOI: 10.1016/j.hrthm.2022.02.031. View

Azarrafiy R, Tsang D, Wilkoff B, Carrillo R . Endovascular Occlusion Balloon for Treatment of Superior Vena Cava Tears During Transvenous Lead Extraction: A Multiyear Analysis and an Update to Best Practice Protocol. Circ Arrhythm Electrophysiol. 2019; 12(8):e007266. DOI: 10.1161/CIRCEP.119.007266. View

Sciria C, Kogan E, Mandler A, Yeo I, Simon M, Kim L . Low Utilization of Lead Extraction Among Patients With Infective Endocarditis and Implanted Cardiac Electronic Devices. J Am Coll Cardiol. 2023; 81(17):1714-1725. DOI: 10.1016/j.jacc.2023.02.042. View

10.

Blomstrom-Lundqvist C, Traykov V, Erba P, Burri H, Nielsen J, Bongiorni M . European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society.... Europace. 2019; 22(4):515-549. PMC: 7132545. DOI: 10.1093/europace/euz246. View

11.

Tarakji K, Chan E, Cantillon D, Doonan A, Hu T, Schmitt S . Cardiac implantable electronic device infections: presentation, management, and patient outcomes. Heart Rhythm. 2010; 7(8):1043-7. DOI: 10.1016/j.hrthm.2010.05.016. View

12.

Lee J, Majmundar M, Kumar A, Thakkar S, Patel H, Sorajja D . Impact of timing of transvenous lead removal on outcomes in infected cardiac implantable electronic devices. Heart Rhythm. 2021; 19(5):768-775. DOI: 10.1016/j.hrthm.2021.12.023. View

13.

Sandoe J, Barlow G, Chambers J, Gammage M, Guleri A, Howard P . Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British.... J Antimicrob Chemother. 2014; 70(2):325-59. DOI: 10.1093/jac/dku383. View

14.

Kusumoto F, Schoenfeld M, Wilkoff B, Berul C, Birgersdotter-Green U, Carrillo R . 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017; 14(12):e503-e551. DOI: 10.1016/j.hrthm.2017.09.001. View

15.

Voigt A, Shalaby A, Saba S . Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol. 2006; 48(3):590-1. DOI: 10.1016/j.jacc.2006.05.016. View

16.

Brunner M, Cronin E, Wazni O, Baranowski B, Saliba W, Sabik J . Outcomes of patients requiring emergent surgical or endovascular intervention for catastrophic complications during transvenous lead extraction. Heart Rhythm. 2013; 11(3):419-25. DOI: 10.1016/j.hrthm.2013.12.004. View

17.

Sridhar A, Lavu M, Yarlagadda V, Reddy M, Gunda S, Afzal R . Cardiac Implantable Electronic Device-Related Infection and Extraction Trends in the U.S. Pacing Clin Electrophysiol. 2017; 40(3):286-293. DOI: 10.1111/pace.13009. View